Eslit, Jesa Mae .

HRN: 27-44-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
CEFUROXIME 1.5GM (VIAL)
07/09/2025
07/15/2025
IV
1.5g
Q8
Nsvd Wbc 38
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: